Maria Teresa Sanz Martinez

Institutions of which they are part

Predoctoral researcher
Translational Immunology

Vall Hebron Institut de Recerca

Doctor
Immunology

Cross-departmental services

Maria Teresa Sanz Martinez

Institutions of which they are part

Predoctoral researcher
Translational Immunology

Vall Hebron Institut de Recerca

Doctor
Immunology

Cross-departmental services

Projects

CARACTERIZACIÓNDE LA FARMACOCINÈTICA DE RITUXIMAB EN PACIENTS AMB MALALTIES RENALS AMB AFECTACIÓ GLOMERULAR

IP: Maria Larrosa Garcia
Collaborators: Mónica Martínez Gallo, J. Bruno Montoro Ronsano, Maria Queralt Gorgas Torner, Irene Agraz Pamplona, Carla Alonso Martinez, Maria Teresa Sanz Martinez, Sonia García García
Funding agency: Societat Catalana de Farmàcia Clínica
Funding: 12000
Reference: SCFC/JOAQUIM.BONAL/2022/LARROSA
Duration: 01/09/2022 - 30/08/2024

Related news

Vall d’Hebron confirms the utility of the Ex Vivo C5b-9 deposition test

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

A study describes a genetic mechanism related to a type of immunodeficiency in women

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.